🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting substances of unknown origin.

Several experts said the popularity for the experimental drug could be connected to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer regulations, risking fines, legal action or imprisonment.

Service Reaction and Content Elimination

According to the social media company, the platform has taken down problematic content and prohibited related keywords and query recommendations. The organization stated it was committed to maintaining the service safe and investing in enhancing compliance measures.

Online Trading Operations

Investigations also found communities with up to nine thousand participants selling retatrutide using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with numerous of members, populated with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at residence.

After moments of entering one group, a vendor posted contact information, where the majority of purchases occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.

Item Details and Costs

Inside these groups, messages show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When questioned how long a injector should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has already seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet authorized … may expose users to potentially significant medical dangers”.